<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>ABSTRACT: BACKGROUND: <z:hpo ids='HP_0000855'>Insulin resistance</z:hpo> (IR) and <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e> are frequently associated in <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">cardiac disease</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The T-786[rightwards arrow]C variant in the promoter region of the endothelial nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase (eNOS) gene has been associated with IR in both non-diabetic and diabetic subjects </plain></SENT>
<SENT sid="2" pm="."><plain>Aim of the study was to assess the reciprocal relationships between T-786[rightwards arrow]C eNOS polymorphism and IR in ischemic and non-ischemic <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>METHOD: A group of 132 patients (108 males, median age 65 years) with global left ventricular (LV) dysfunction secondary to ischemic or non-<z:e sem="disease" ids="C0151744" disease_type="Disease or Syndrome" abbrv="IHD">ischemic heart disease</z:e> was enrolled </plain></SENT>
<SENT sid="4" pm="."><plain>Genotyping of T-786[rightwards arrow]C eNOS gene promoter, fasting <z:chebi fb="105" ids="17234">glucose</z:chebi>, insulin, and <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> (defined as HOMA-IR index &gt; 2.5) were determined in <z:hpo ids='HP_0000001'>all</z:hpo> patients </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Genotyping analysis yielded 37 patients homozygous for the T allele (TT), 70 heterozygotes (TC) and 25 homozygous for C (CC) </plain></SENT>
<SENT sid="6" pm="."><plain>Patients with CC genotype had significantly higher systemic arterial pressure, blood <z:chebi fb="105" ids="17234">glucose</z:chebi>, plasma insulin and HOMA index levels than TT </plain></SENT>
<SENT sid="7" pm="."><plain>At multivariate logistic analysis, the history of <z:hpo ids='HP_0000822'>hypertension</z:hpo> and the genotype were the only predictors of IR </plain></SENT>
<SENT sid="8" pm="."><plain>In particular, CC genotype increased the risk of IR (CI% 1.4-15.0, p &lt; 0.01) 4.5-fold </plain></SENT>
<SENT sid="9" pm="."><plain>The only parameter independently associated with the extent of LV dysfunction and the presence of <z:hpo ids='HP_0001635'>heart failure</z:hpo> (HF) was the HOMA index (2.4 CI% 1.1-5.6, p &lt; 0.04) </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: T-786[rightwards arrow]C eNOS polymorphism was the major independent determinant of IR in a population of patients with ischemic and non-ischemic <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>The results suggest that a condition of primitive eNOS lower expression can predispose to an impairment of <z:chebi fb="105" ids="17234">glucose</z:chebi> homeostasis, which in turn is able to affect the severity of <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">heart disease</z:e> </plain></SENT>
</text></document>